Combination of a MCL-1 inhibitor and a taxane compound, uses and pharmaceutical compositions thereof
US10765680B2 · kind B2 · utility
0Cited by
7References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 5, 2018 |
| Grant date | Sep 8, 2020 |
| Priority date | — |
| Expiry date | Jan 5, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A combination comprising a MCL-1 inhibitor and a taxane compound, and compositions and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.